NCT00380887已完成不适用
An Open-Label, Single-Dose, Randomized, 4-Period, Partial Crossover Bioequivalence/Bioavailability Study Among Four New Formulations of Premarin 0.45 mg/Medroxyprogesterone Acetate (MPA) 1.5 mg Compared With a Reference Formulation of Premarin/MPA (Prempro) 0.45 mg/1.5 mg in Healthy Postmenopausal Women
Wyeth is now a wholly owned subsidiary of Pfizer0 个研究点目标入组 54 人开始时间: 2005年6月最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 54
研究概览
简要总结
The purpose of this study is to determine bioequivalence and bioavailability of four different Premarin/MPA test formulations versus the current formulation for Prempro.
研究设计
- 研究类型
- Observational
- 观察模型
- Defined Population
- 时间视角
- Other
入排标准
- 年龄范围
- 35 Years 至 70 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Healthy postmenopausal women aged 35 to 70 years
- •Nonsmoker or smoker of less than 10 cigarettes per day
排除标准
- •History or presence of clotting disorders
- •History or presence of cancer
- •Presence of HIV, hepatitis B or hepatitis C
- •History of drug or alcohol abuse
研究者
相似试验
已完成
1 期
Study Comparing Bioavailability of 3 New Formulations of Premarin/MPA With Premarin/MPA (PREMPRO) Reference FormulationEstrogen Replacement TherapyNCT00401219Wyeth is now a wholly owned subsidiary of Pfizer
已完成
1 期
A Study to Assess the Relative Bioavailability of 4 Formulations of Fentanyl Transdermal System Compared Against DUROGESIC Fentanyl Transdermal Patch After Single Application in Healthy VolunteersHealthyNCT01717157Janssen Research & Development, LLC32
已完成
1 期
A Study to Determine the Bioequivalence of Alogliptin and Pioglitazone When Administered as Individual Tablets and as Fixed-Dose Combination (FDC)-SYR-322-4833 BL Tablets to Healthy Russian ParticipantsHealthy VolunteersNCT03501277Takeda72
已完成
1 期
Bioequivalence Study of 8 mg Perindopril Tert-Butylamine / 2.5 mg Indapamide / 10 mg Amlodipine Tablets Versus 10 mg Perindopril Arginine / 2.5 mg Indapamide / 10 mg Amlodipine Film-Coated Tablets in Healthy VolunteersBioequivalenceHealthy SubjectsNCT05470764Darnitsa Pharmaceutical Company52
已完成
1 期
Bioequivalence Study of Test and Reference 120 mg Etoricoxib Film-coated Tablets in Healthy VolunteersBioequivalenceHealthy SubjectsNCT05014490Darnitsa Pharmaceutical Company28